Opioids are mainly used to treat both acute and chronic pain. Several opioids are metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and methadone). Polymorphisms in CYP2D6 have been studied for an association with the clinical effect and safety of these drugs. Other genes that have been studied for their association with opioid clinical effect or adverse events include OPRM1 (mu receptor) and COMT (catechol-O-methyltransferase). This guideline updates and expands the 2014 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and codeine therapy and includes a summation of the evidence describing the impact of CYP2D6, OPRM1, and COMT on opioid analgesia and adverse events. We provide therapeutic recommendations for the use of CYP2D6 genotype results for prescribing codeine and tramadol and describe the limited and/or weak data for CYP2D6 and hydrocodone, oxycodone, and methadone, and for OPRM1 and COMT for clinical use.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249478 | PMC |
| http://dx.doi.org/10.1002/cpt.2149 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pharmacogenetics of opioid medications for relief of labor pain and post-cesarean pain: a systematic review and meta-analysis.
Eur J Clin Pharmacol
January 2025
Department of Pharmaceutical Sciences, University of Piemonte Orientale "A. Avogadro", Largo Donegani 2, 28100, Novara, Italy.
Objective: Several studies have attempted to identify genetic determinants of clinical response to opioids administered during labor or after cesarean section. However, their results were often contrasting. A systematic review and meta-analysis was conducted to quantitatively assess the association between gene polymorphisms and clinical outcomes of opioid administration in the treatment of labor pain and post-cesarean pain.
View Article and Find Full Text PDFAssociations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair - a prospective study protocol.
BMC Med Genomics
December 2024
Pharmaceutical Care, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Background: Postoperative pain is a common complication following surgery, with severity and duration varying between patients. Chronic postoperative pain after inguinal hernia surgery has an incidence rate of approximately 10%. Risk factors for acute and chronic pain following hernia surgery include age, sex, psychosocial factors, and demographic background.
View Article and Find Full Text PDFPharmacogenomic variation and sedation outcomes during early intensive care unit admission: A pragmatic study.
Clin Transl Sci
December 2024
Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
Article Synopsis
- Unpredictable reactions to sedatives and analgesics in critically ill patients on mechanical ventilation may stem from genetic differences.
- The study aimed to explore the relationship between pharmacogenomic variations and sedation outcomes, while also assessing ICU patients' views on pharmacogenomic testing.
- The researchers found that while participants showed a median of 2 altered pharmacogenomic phenotypes, there were no significant links between these genetic variations and sedation effectiveness; however, ICU patients generally had positive attitudes towards pharmacogenomic testing.
Risk Factors for Increased Opioid Use During Postoperative Intensive Care.
Crit Care Explor
November 2024
Duke University Department of Anesthesiology and Critical Care Medicine, Critical Care and Perioperative Population Health Research (CAPER) Group, Durham, NC.
Importance: In the ICU, opioids treat pain and improve ventilator tolerance as part of an analgosedation approach. Identifying predictors of opioid consumption during the ICU course might highlight actionable items to reduce opioid consumption.
Objectives: To identify risk factors for opioid use during a postoperative ICU course.
Genetic Associations of Persistent Opioid Use After Surgery Point to OPRM1 but Not Other Opioid-Related Loci as the Main Driver of Opioid Use Disorder.
Genet Epidemiol
January 2025
Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Article Synopsis
- Persistent opioid use after surgery increases the risk of opioid use disorder, overdose, and death, but the genetic factors behind this issue were largely unknown.
- A study with around 40,000 participants identified some genetic signals associated with persistent opioid use, particularly focusing on the OPRM1 gene, where two variants showed significant results.
- The findings strengthen the link between opioid dependence and addiction, but the lack of consistent associations in other genes questions the reliability of previous studies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!